Xaver Schiel

2.0k total citations
36 papers, 1.2k citations indexed

About

Xaver Schiel is a scholar working on Oncology, Epidemiology and Emergency Medicine. According to data from OpenAlex, Xaver Schiel has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Epidemiology and 9 papers in Emergency Medicine. Recurrent topics in Xaver Schiel's work include Neutropenia and Cancer Infections (19 papers), Hematological disorders and diagnostics (9 papers) and Blood disorders and treatments (7 papers). Xaver Schiel is often cited by papers focused on Neutropenia and Cancer Infections (19 papers), Hematological disorders and diagnostics (9 papers) and Blood disorders and treatments (7 papers). Xaver Schiel collaborates with scholars based in Germany, United States and Curacao. Xaver Schiel's co-authors include Helmut Ostermann, Oliver A. Cornely, Georg Maschmeyer, Dieter Buchheidt, Michael Vogeser, Ute Spöhrer, Wolfgang Hiddemann, Marcus Hentrich, Silke Neumann and Marie von Lilienfeld‐Toal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and FEBS Letters.

In The Last Decade

Xaver Schiel

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xaver Schiel Germany 19 570 542 267 169 134 36 1.2k
Ilaria Caviglia Italy 18 513 0.9× 449 0.8× 384 1.4× 168 1.0× 143 1.1× 40 999
Hamdi Akan Türkiye 26 555 1.0× 775 1.4× 602 2.3× 147 0.9× 471 3.5× 106 1.8k
A. Fernández‐Sevilla Spain 17 523 0.9× 458 0.8× 196 0.7× 336 2.0× 40 0.3× 24 1.3k
Isabel Sánchez‐Ortega Spain 17 454 0.8× 404 0.7× 326 1.2× 122 0.7× 374 2.8× 50 1.1k
G Todeschini Italy 19 764 1.3× 264 0.5× 214 0.8× 216 1.3× 391 2.9× 32 1.6k
Montserrat Arnán Spain 19 469 0.8× 537 1.0× 418 1.6× 188 1.1× 242 1.8× 53 1.3k
Alain Kentos Belgium 18 284 0.5× 288 0.5× 199 0.7× 117 0.7× 330 2.5× 58 1.4k
Douglas K. Hawley United States 6 741 1.3× 325 0.6× 164 0.6× 231 1.4× 78 0.6× 8 984
M Giacchino Italy 17 365 0.6× 523 1.0× 463 1.7× 97 0.6× 75 0.6× 38 960
S. Špánik Slovakia 20 556 1.0× 337 0.6× 382 1.4× 151 0.9× 48 0.4× 79 1.4k

Countries citing papers authored by Xaver Schiel

Since Specialization
Citations

This map shows the geographic impact of Xaver Schiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xaver Schiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xaver Schiel more than expected).

Fields of papers citing papers by Xaver Schiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xaver Schiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xaver Schiel. The network helps show where Xaver Schiel may publish in the future.

Co-authorship network of co-authors of Xaver Schiel

This figure shows the co-authorship network connecting the top 25 collaborators of Xaver Schiel. A scholar is included among the top collaborators of Xaver Schiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xaver Schiel. Xaver Schiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fiegl, Michael, Michael Unterhalt, Wolfgang Kern, et al.. (2013). Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. Leukemia. 28(5). 1001–1007. 22 indexed citations
3.
Neumann, Silke, Stefan W. Krause, Georg Maschmeyer, Xaver Schiel, & Marie von Lilienfeld‐Toal. (2013). Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Annals of Hematology. 92(4). 433–442. 76 indexed citations
4.
Hentrich, Marcus, Helmut Ostermann, Joachim Kienast, et al.. (2006). IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: A randomized, controlled, multiple-center trial*. Critical Care Medicine. 34(5). 1319–1325. 54 indexed citations
6.
Penack, Olaf, T. Beinert, Dieter Buchheidt, et al.. (2006). Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 85(9). 639–639. 1 indexed citations
8.
Vogeser, Michael, Xaver Schiel, & Ute Spöhrer. (2005). Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry. Clinical Chemistry and Laboratory Medicine (CCLM). 43(7). 730–4. 39 indexed citations
9.
Hentrich, Marcus, Daniel Oruzio, Gundula Jäger, et al.. (2004). Impact of human herpesvirus‐6 after haematopoietic stem cell transplantation. British Journal of Haematology. 128(1). 66–72. 108 indexed citations
10.
Rieger, C., Michael Fiegl, Johanna Tischer, Helmut Ostermann, & Xaver Schiel. (2004). Incidence and severity of ifosfamide-induced encephalopathy. Anti-Cancer Drugs. 15(4). 347–350. 40 indexed citations
11.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2003). Diagnosis and treatment of documented infections in neutropenic patients. Annals of Hematology. 82(S2). S127–S132. 76 indexed citations
12.
Vogeser, Michael, Ute Spöhrer, & Xaver Schiel. (2003). Determination of Itraconazole and Hydroxyitraconazole in Plasma by Use of Liquid Chromatography-Tandem Mass Spectrometry with On-line Solid-Phase Extraction. Clinical Chemistry and Laboratory Medicine (CCLM). 41(7). 915–20. 29 indexed citations
13.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2001). Dokumentierte Infektionen bei Neutropenie - Empfehlungen zu Diagnostik und Therapie. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1085–1090. 2 indexed citations
14.
Buchheidt, Dieter, Angelika Böhme, Oliver A. Cornely, et al.. (2001). Documented infections with neutropenia: therapeutic and diagnostic recommendations. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1085–1090. 2 indexed citations
15.
Kastenbauer, Stefan, Frank Winkler, Gunther Fesl, et al.. (2001). Acute Severe Spinal Cord Dysfunction in Bacterial Meningitis in Adults. Archives of Neurology. 58(5). 806–806. 48 indexed citations
17.
Karthaus, Meinolf, Dieter Buchheidt, Wolfgang Hiddemann, et al.. (1999). European Surveillance of Infections in Cancer Patients – ESIC. Chemotherapy. 45(4). 237–241. 5 indexed citations
18.
Buchheidt, Dieter, Wolfgang Hiddemann, Xaver Schiel, et al.. (1999). European Surveillance of Infections and Risk Factors in Cancer Patients. European Journal of Clinical Microbiology & Infectious Diseases. 18(2). 161–163. 2 indexed citations
19.
Rose‐John, Stefan, et al.. (1990). Studies on the structure and regulation of the human hepatic interleukin‐6 receptor. European Journal of Biochemistry. 190(1). 79–83. 94 indexed citations
20.
Schiel, Xaver, et al.. (1990). Microheterogeneity of human interleukin 6 synthesized by transfected NIH/3T3 cells: Comparison with human monocytes, fibroblasts and endothelial cells. European Journal of Immunology. 20(4). 883–887. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026